M1 KLINIKEN AG |
Market Closed -
Other stock markets
|
After market 12:37:16 pm | |||
| 16.9 EUR | +7.30% |
|
16.9 | 0.00% |
| Feb. 05 | M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares | MT |
| 2023 | M1 Kliniken Takes Ownership of Dutch Online Pharmacy | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 39.38 and 27.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +50.00% | 311M | - | ||
| -15.68% | 16.57B | B+ | ||
| +4.50% | 12.51B | B | ||
| +4.48% | 11.69B | B+ | ||
| +6.18% | 10.36B | B+ | ||
| +25.64% | 8.38B | B | ||
| -2.87% | 7.75B | A- | ||
| +20.39% | 7.12B | D | ||
| +3.74% | 6.6B | B- | ||
| +46.01% | 4.54B | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- M12 Stock
- Ratings M1 Kliniken AG